Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome - A literature review
Abstract Background Capecitabine (Xeloda®) is a cytotoxic, antimetabolite chemotherapeutic agent. Its most common adverse events are diarrhea, hand-foot syndrome (HFS), hyperbilirubinemia, hyperpigmentation, fatigue, abdominal pain, and other gastrointestinal effects. HFS or palmar-plantar erythrody...
Bewaard in:
Hoofdauteurs: | , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Sociedade Brasileira de Dermatologia,
2023-06-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Wees de eerste die reageert!